Below are the most recent publications written about "Inflammasomes" by people in Profiles.
-
Austermeier S, Cheng KO, Dietschmann A, Vascelli G, Montaño DE, Hitzler SUJ, Skurk KS, Fernández-Fernández C, Saloni S, Westermann S, Jaeger M, Jablonowski N, Wisgott S, Elshafee O, Brachelente C, de Graaf DM, Próchnicki T, Latz E, Wirtz S, Becker C, Renga G, Oikonomou V, Hube B, Donders GGG, Pekmezovic M, Zelante T, Gresnigt MS. Local albumin excess exacerbates Candida albicans-induced inflammasome activation linked with hyperinflammation during vulvovaginal candidiasis. Nat Commun. 2026 Oct 29; 17(1).
-
Humphries F. Misfirin' pyrin. Sci Immunol. 2026 08 07; 11(122):eaei8902.
-
Li T, Castro-Gomez S, Botella Lucena P, Vieira-Saecker A, Schwartz S, Ding Y, Deng Y, Gou M, Stein V, Golenbock DT, Latz E, Heneka MT. Inflammasome adaptor ASC promotes sustained neuroinflammation and mild cognitive impairment in a closed-head injury model. J Clin Invest. 2026 Apr 01; 136(7).
-
de Farias IS, Duarte-Barbosa M, Salazar N, Andreata-Santos R, de Lucena VWL, Maricato JT, Gazzinelli RT, Janini LMR, Bortoluci KR. NLRP3 inflammasome activation in astrocytes restricts SARS-CoV-2 through gasdermin-D-driven IL-1? release. Front Immunol. 2025; 16:1703765.
-
Shen Z, Wang C, Fu TM. Supramolecular Assemblies Drive Activation of Inflammasomes. Adv Exp Med Biol. 2026; 1514:41-54.
-
Szabo G, Babuta M, Ribeiro M. CLINICAL IMPLICATIONS OF INFLAMMATION IN STEATOTIC LIVER DISEASE: HETEROGENEITY OF NEUTROPHILS IN TISSUE INJURY AND HOST DEFENSE. Trans Am Clin Climatol Assoc. 2026; 136:274-286.
-
Ravichandran KA, Brosseron F, McManus RM, Ising C, Görgen S, Schmidt SV, Santarelli F, Lee SY, Jung H, Chung WS, Kim CH, Ruiz Laza A, Ruiz de Almodóvar C, Ramirez A, Latz E, Heneka MT. Enhancing Tyro3 signaling ameliorates IL-1? production through STAT1 in Alzheimer's disease models. J Leukoc Biol. 2025 Dec 01; 117(12).
-
Koerber RM, Krollmann C, Cieslak K, Tregel E, Saenz ML, Brümmendorf TH, Koschmieder S, Griesshammer M, Gütgemann I, Baldauf CK, Fischer T, Brossart P, Kolbe CC, Latz E, Wolf D, Teichmann LL. NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms. Nat Commun. 2025 Nov 26; 16(1):10591.
-
Krause K, Franch Arroyo S, Ugolini M, Kueck T, Sullivan TJ, Gálvez EJC, Muenzner M, Goosmann C, Brinkmann V, Frese CK, Alagesan K, Vierbuchen T, Heine H, Resch U, Sander LE, Charpentier E. Streptococcus pyogenes EVs induce the alternative inflammasome via caspase-4/-5 in human monocytes. EMBO Rep. 2025 10; 26(19):4847-4885.
-
Weber ANR, McManus RM, Hornung V, Geyer M, Kuemmerle-Deschner JB, Latz E. The expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets. Nat Immunol. 2025 Sep; 26(9):1453-1466.